ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Systemic Diseases

May 15, 2020
A medium-sized RCT from the Imperial College. The research question are of interest for all cardiovascular, thoracic, and general surgeons as well as all healthcare professionals. 
March 20, 2020
Interesting input from a Stanford expert on the hottest topic on the planet at the moment.
September 22, 2019
The authors point out that randomized trials of incentive spirometry have failed to mitigate early postoperative fevers, traditionally attributed to atelectasis.
August 14, 2019
A comprehensive audio lecture from an academic pathologist on non-malignant pulmonary lesions.
August 1, 2019
Using deep learning employing data from over 700,000 patients (6 billion data points), an algorithm for continuous prediction of the risk of acute kidney injury (AKI) was developed. The model correctly predicted over 90% of AKI requiring dialysis with a lead time of up to 48 hours, with 2 false alerts for every true alert.
April 12, 2019
The debate over the utility of postoperative incentive spirometry continues. In this instance, the use of a high-tech incentive spirometer that included audible reminders and use tracking was associated with clinical benefit. 
February 6, 2019
In this prospective single-institution study, functional status trajectory one year after intervention was compared for transcatheter (TAVR) versus surgical aortic valve replacement (SAVR).  A moderate/large decline compared to preintervention status occurred in 23% of TAVR patients and 4% of SAVR patients.  A frailty index, postoperative delirium, a
July 6, 2018
This retrospective study of 328 patients undergoing resection for non-small cell lung cancer demonstrated that sarcopenia determined by psoas muscle mass on computed tomography was associated with increased postoperative complications and was an independent predictor of survival.
May 3, 2018
The latest on portable venovenous ECMO in a cohort in which half of the subjects died after a resource-intensive treatment. The results of the relevant EOLIA trial are keenly awaited.
April 13, 2018
The authors studied patients after resection of stage I non-small cell lung cancer.  They found that nearly one-third had decreased muscle one year postoperatively, which was associated with poor performance status and decreased overall and cancer-specific survival.  

Pages